The Texas Nursing Home COVID-19 Outbreak: Did the Medical Director Launch a Questionable Observation Study or Practice Good Crisis Medicine?

The Texas Nursing Home COVID-19 Outbreak Did the Medical Director Launch a Questionable Observation Study or Practice Good Crisis Medicine

A physician and medical director of a Texas nursing home is under scrutiny as the call was made to administer hydroxychloroquine to many elderly COVID-19 patients after an outbreak nearly two weeks ago. Known as the Resort at Texas City, the physician, Robin Armstrong, made the call based on medical judgement and the conditions and constraints faced. This was the drug that President Donald Trump touted on national television as a “game changer.” However, the drug is not approved and is currently undergoing multiple clinical trials around the world. Did this nursing home initiate an observational study on unsuspecting sick and elderly residents? Or did Dr. Armstrong simply make the best call given tough circumstances?

Hydroxychloroquine isn’t Proven Yet for a Safe & Effective COVID-19 Treatment

TrialSite News recently summarized the status of this anti-malarial drug in recent studies. TrialSite News asked the question ‘Is anti-malarial drug a game changer?' Not yet, evidence-based data is not sufficient at this point in time.

We noted that despite the “game changer” status and the fact that the U.S. Food and Drug Administration authorized the use of the drug for emerge...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee